Lifevantage Affirms FY2025 Adj EPS Guidance from $0.70-0.80 to $0.70-0.80 vs $0.72 Est; Affirms FY2025 Sales Guidance from $200.00M-210.00M to $200.00M-210.00M vs $204.80M Est
Portfolio Pulse from Benzinga Newsdesk
Lifevantage has reaffirmed its FY2025 adjusted EPS guidance at $0.70-0.80, aligning with analyst estimates of $0.72. The company also maintained its FY2025 sales guidance at $200-210 million, close to the $204.80 million analyst estimate.
October 29, 2024 | 8:27 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Lifevantage reaffirmed its FY2025 EPS and sales guidance, aligning closely with analyst estimates, indicating stability in its financial outlook.
The reaffirmation of guidance suggests stability and predictability in Lifevantage's financial performance. The alignment with analyst estimates indicates that the market has already priced in these expectations, likely resulting in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100